Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
J Clin Invest ; 95(3): 1018-25, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7883949

ABSTRACT

The ability of alpha-tocopherol to reduce restenosis after angioplasty was tested in a rabbit model in which angioplasty was performed on established atherosclerotic lesions. Lesions induced by 4 wk of cholesterol feeding after focal desiccation of femoral arteries were balloon dilated. 3 wk after angioplasty, angiographically determined minimum luminal diameters were less in the untreated group (0.80 +/- 0.51 mm) than in the group treated with oral alpha-tocopherol beginning 19 d before angioplasty (1.38 +/- 0.29 mm; P < 0.01). The cross-sectional area of the intima-media was greater in the untreated group (1.18 +/- 0.48 mm2) than in the alpha-tocopherol group (0.62 +/- 0.25 mm2, P < 0.0001). These differences were not due to vasoconstriction or altered plasma cholesterol. Alpha-tocopherol thus reduced restenosis after angioplasty in this model. In rabbit vascular smooth muscle cells, oxidized low density lipoprotein stimulated DNA synthesis. Alpha-tocopherol treatment inhibited DNA synthesis stimulated by oxidized low density lipoprotein, but not by serum. The findings are consistent with the hypothesis that oxidized lipids can stimulate hyperplasia and that antioxidants may limit hyperplasia by inhibiting either the oxidation or the proliferative effects of oxidants on cells.


Subject(s)
Angioplasty, Balloon , Arteriosclerosis/surgery , Vitamin E/therapeutic use , Administration, Oral , Animals , Aorta/cytology , Arteriosclerosis/prevention & control , Cell Division/drug effects , Cells, Cultured , Disease Models, Animal , Femoral Artery/pathology , Hyperplasia/etiology , Lipid Peroxidation , Lipoproteins, LDL/pharmacology , Male , Muscle Development , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/growth & development , Rabbits , Recurrence , Tunica Intima/pathology , Vitamin E/blood
2.
J Am Coll Cardiol ; 20(7): 1642-9, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1452939

ABSTRACT

OBJECTIVES: To simulate a human catheterization laboratory setting of controlled reperfusion during myocardial infarction, regional infusion of commercially available Buckberg cardioplegic solution and peripheral vented bypass were administered in the closed chest dog. BACKGROUND: Studies in open-chest dogs have demonstrated a significant reduction in infarct size and improvement in regional wall motion with a similar controlled reperfusion method using infusion of substrate-enriched (Buckberg) cardioplegic solution during cardiopulmonary bypass coupled with left ventricular venting. METHODS: After 100 or 180 min of balloon occlusion of the proximal left anterior descending artery, controlled reperfusion was performed with cardioplegic infusion and vented bypass. Dogs matched for occlusion time underwent balloon deflation without bypass or cardioplegia (uncontrolled reperfusion groups). Microspheres were used to quantify coronary ischemia during balloon inflation. All four groups (n = 8 to 9 per group) were followed up at 1 week to determine regional wall motion and infarct size. RESULTS: Qualitative echocardiographic analysis demonstrated no significant difference among groups in recovery of regional wall motion at 1 week; however, wall motion improved significantly in all groups between the ischemia and 1-week recovery periods. The histologic infarct size compared with the area at risk for dogs with uncontrolled versus controlled reperfusion, respectively, was 17.9 +/- 10.5% versus 31.9 +/- 8.3% (p < 0.05) for dogs with 100 min of occlusion and 40.1 +/- 11.7% versus 46.2 +/- 8.4% (p = NS) for dogs with 180 min of occlusion. A greater rate-pressure product in the dogs with controlled reperfusion after 100 min of occlusion (p < 0.05) may explain the larger infarct size observed for that group. CONCLUSIONS: These results demonstrate that regional infusion of substrate-enriched cardioplegic solution in combination with peripheral vented bypass does not further reduce infarct size after prolonged ischemia in the closed chest dog (compared with uncontrolled reperfusion).


Subject(s)
Cardioplegic Solutions/therapeutic use , Cardiopulmonary Bypass/standards , Myocardial Infarction/therapy , Myocardial Reperfusion/standards , Animals , Blood Flow Velocity , Cardioplegic Solutions/administration & dosage , Cardiopulmonary Bypass/instrumentation , Cardiopulmonary Bypass/methods , Clinical Protocols/standards , Decision Trees , Disease Models, Animal , Dogs , Echocardiography , Evaluation Studies as Topic , Hemodynamics , Injections, Intra-Arterial , Isotope Labeling , Male , Microspheres , Myocardial Infarction/diagnostic imaging , Myocardial Infarction/pathology , Myocardial Reperfusion/instrumentation , Myocardial Reperfusion/methods
3.
Planta ; 103(3): 254-62, 1972 Sep.
Article in French | MEDLINE | ID: mdl-24481559

ABSTRACT

Synchronization of Euglena gracilis (Z) on lactate medium is shown to be independent of illumination. The existence of a mitochondrial cycle in lightgrown as well as in dark-grown Euglena is demonstrated. When RNA synthesis is studied by pulse labeling with tritiated uracil in synchronously growing cells, a discontinuous RNA synthesis is found. Two peaks of preferential RNA synthesis in dark-grown cells and three peaks in light-grown cells are seen; the significance of the third peak of RNA synthesis in light-grown Euglena is discussed.

SELECTION OF CITATIONS
SEARCH DETAIL
...